International society of geriatric oncology (SIOG) clinical practice recommendations for the use of bisphosphonates in elderly patients
- 1 March 2007
- journal article
- practice guideline
- Published by Elsevier in European Journal Of Cancer
- Vol. 43 (5), 852-858
- https://doi.org/10.1016/j.ejca.2006.12.006
Abstract
No abstract availableKeywords
This publication has 38 references indexed in Scilit:
- Bisphosphonates for malignancy-related bone disease: current status, future developmentsSupportive Care in Cancer, 2006
- Practical Guidelines for the Prevention, Diagnosis, and Treatment of Osteonecrosis of the Jaw in Patients With CancerJournal of Oncology Practice, 2006
- Predictive Value of Bone Resorption and Formation Markers in Cancer Patients With Bone Metastases Receiving the Bisphosphonate Zoledronic AcidJournal of Clinical Oncology, 2005
- HypodermoclysisJournal of Infusion Nursing, 2005
- Bone Turnover Markers as Predictors of Skeletal Complications in Prostate Cancer, Lung Cancer, and Other Solid TumorsJNCI Journal of the National Cancer Institute, 2005
- Safety and Pain Palliation of Zoledronic Acid in Patients with Breast Cancer, Prostate Cancer, or Multiple Myeloma Who Previously Received Bisphosphonate TherapyThe Oncologist, 2004
- Extended Safety Profile of Oral Clodronate After Long-Term Use in Primary Breast Cancer PatientsDrug Safety, 2003
- Long‐term follow‐up of a prospective, double‐blind, placebo‐controlled randomized trial of clodronate in multiple myelomaBritish Journal of Haematology, 2001
- A randomized trial of the effect of clodronate on skeletal morbidity in multiple myelomaBritish Journal of Haematology, 1998
- Is there such a thing as geriatric pain?Pain, 1991